gip/glp-1 tirzepatide Effects of tirzepatide, a dual GIP and GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Eli Lilly's GIP/GLP-1 Dual Agonist

These units are not the same as International Units (IU), a separate measurement used for some hormones, vitamins, or biologics

They are especially relevant right now, because the FDA issued 30 warning letters to compounded GLP-1 telehealth companies in early 2026, and on April 30, 2026 proposed a rule that would - if finalized - permanently close the large-scale compounding pathway for semaglutide and tirzepatide

Although these discussions should never replace medical advice, they offer valuable insight into the questions and concerns many people have while taking the medication

Most people will start with a dose of 2.5 mg once per week

This applies to VitaStir and every other compounded tirzepatide provider

Retrieved from Tomiyama, A